Microstent reduces medication use

Article

Intracanalicular device providing durable IOP reduction as standalone procedure

The open study enrolled 69 patients at 7 centres. Forty eyes underwent microinvasive glaucoma surgery (MIGS) alone and 29 had combination phacoemulsification. After one year of follow-up in both subgroups, both mean IOP and mean medication use were significantly reduced from baseline. No serious complications occurred and there were no cases of device migration or perforation.

"MIGS is an evolving therapeutic option conceived to treat glaucoma surgically more safely than trabeculectomy while still maintaining traditional options," claimed Dr Samuelson, founding partner, Minnesota Eye Consultants, Minneapolis, Minnesota, USA, and medical monitor for the multinational study. "However, the MIGS procedures are often performed in conjunction with cataract extraction, which makes it difficult to know what is the pressure effect from the MIGS procedure itself.

"Not only does the stent occupy nearly 8 mm of Schlemm's canal, providing access for aqueous to multiple collector channels, but it also dilates the canal," Dr Samuelson said. "Laboratory studies have shown that this true stenting further improves aqueous outflow."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.